As a locally owned and managed company, SAFELINE understands the unique healthcare needs of patients in South Africa. In our quest to best serve our people, SAFELINE sources Neonatal and Anaesthetic products from various countries. We are proud that we are able to offer these high quality products to the South African market at cost effective prices.


When an infant is born prematurely, immense costs are involved in saving the life of this precious baby. One of the main threats to premature infants is Respiratory Distress Syndrome (RDS), caused by a lack of surfactant needed for the baby to breathe. For more information on premature infants and related complications, please visit

By offering superior products for the treatment of difficulties caused by premature birth, as well as supporting CME (Continued Medical Education), SAFELINE provides essential support to the healthcare professionals of premature babies. The knowledge gleaned during CME activities further enhance the excellent care these professionals provide to infants requiring special care in their units.


Over the past 15 years, SAFELINE has become a key player in the South African anaesthetic industry by supplying various anaesthetic agents to private and government hospitals as well as veterinarians. SAFELINE has successfully supplied state tenders with our range of anaesthetic products for over a decade, saving the state sector millions of rands and providing firm evidence of the quality of our products.

Quality      Trust     Confidence   

© Safeline Pharmaceuticals (PTY) LTD. All Rights Reserved. | Disclaimer